Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy

AIMS: An adjuvant oxaliplatin-based regimen is the standard of care for patients with stage III colorectal cancer (CRC). Few reports have compared the clinicopathological features and oncological outcomes of such treatment between patients with early (≤1 year) and late recurrence (>1 year). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Tang, Tsai, Hsiang-Lin, Chen, Yen-Cheng, Li, Ching-Chun, Huang, Ching-Wen, Chen, Po-Jung, Su, Wei-Chih, Chang, Tsung-Kun, Yeh, Yung-Sung, Yin, Tzu-Chieh, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839400/
https://www.ncbi.nlm.nih.gov/pubmed/36644232
http://dx.doi.org/10.1155/2023/2439128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839400/
https://www.ncbi.nlm.nih.gov/pubmed/36644232
http://dx.doi.org/10.1155/2023/2439128

Ejemplares similares